DK0931265T3 - Diagnistisk metode for aterosklerose - Google Patents

Diagnistisk metode for aterosklerose

Info

Publication number
DK0931265T3
DK0931265T3 DK97939604T DK97939604T DK0931265T3 DK 0931265 T3 DK0931265 T3 DK 0931265T3 DK 97939604 T DK97939604 T DK 97939604T DK 97939604 T DK97939604 T DK 97939604T DK 0931265 T3 DK0931265 T3 DK 0931265T3
Authority
DK
Denmark
Prior art keywords
atherosclerosis
diagnostic method
level
hydroxyphenylacetaldehyde
lysine
Prior art date
Application number
DK97939604T
Other languages
English (en)
Inventor
Jay W Heinecke
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Application granted granted Critical
Publication of DK0931265T3 publication Critical patent/DK0931265T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/323—Arteriosclerosis, Stenosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK97939604T 1996-09-09 1997-09-03 Diagnistisk metode for aterosklerose DK0931265T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/709,700 US5731208A (en) 1996-09-09 1996-09-09 Method of detecting conditions indicative of atherosclerosis
PCT/US1997/015115 WO1998010295A1 (en) 1996-09-09 1997-09-03 Diagnostic method for atherosclerosis

Publications (1)

Publication Number Publication Date
DK0931265T3 true DK0931265T3 (da) 2002-07-29

Family

ID=24850989

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97939604T DK0931265T3 (da) 1996-09-09 1997-09-03 Diagnistisk metode for aterosklerose

Country Status (11)

Country Link
US (1) US5731208A (da)
EP (1) EP0931265B1 (da)
JP (1) JP3553612B2 (da)
AT (1) ATE217089T1 (da)
AU (1) AU4165297A (da)
CA (1) CA2264754C (da)
DE (1) DE69712352T2 (da)
DK (1) DK0931265T3 (da)
ES (1) ES2176778T3 (da)
PT (1) PT931265E (da)
WO (1) WO1998010295A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6727102B1 (en) 1997-06-20 2004-04-27 Leuven Research & Development Vzw Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins
US6133039A (en) * 1998-02-09 2000-10-17 Washinton University In vivo method for determination of oxidative stress
US6096556A (en) * 1998-02-09 2000-08-01 Washington University Method for the determination of oxidative stress
SE9802402D0 (sv) 1998-07-03 1998-07-03 Karolinska Innovations Ab Method of diagnosing cardiovascular disease and early atherosclerosis
US6309888B1 (en) * 1998-09-04 2001-10-30 Leuven Research & Development Vzw Detection and determination of the stages of coronary artery disease
ATE343130T1 (de) * 1999-12-29 2006-11-15 Perkinelmer Life Sciences Inc Testtablett, kit und verfahren zum screening von körperflüssigkeiten von neugeborenen durch tandem-massenspektrometrie
US7780950B2 (en) * 2002-01-02 2010-08-24 The Cleveland Clinic Foundation Systemic marker for monitoring anti-inflammatory and antioxidant actions of therapeutic agents
BR0206273A (pt) * 2001-01-02 2006-11-21 Cleveland Clinic Foundation testes diagnósticos para caracterizar o risco de um paciente humano de desenvolver ou apresentar doença cardiovascular e para avaliar um agente terapêutico para doença cardiovascular em um sujeito suspeito de apresentar ou apresentando doença cardiovascular, e, kit
US6939716B2 (en) * 2001-09-19 2005-09-06 Washington University Method for detecting conditions indicative of sepsis
US7459286B1 (en) 2003-10-22 2008-12-02 The Cleveland Clinic Foundation Assessing the risk of a major adverse cardiac event in patients with chest pain
AU2004296829A1 (en) 2003-12-05 2005-06-23 The Cleveland Clinic Foundation Risk markers for cardiovascular disease
US20050181451A1 (en) * 2004-02-12 2005-08-18 Bates Harold M. Detection of asymptomatic coronary artery disease using atherogenic proteins and acute phase reactants
WO2006020498A2 (en) 2004-08-11 2006-02-23 The Cleveland Clinic Foundation Therapeutic agents and methods for cardiovascular disease
US9744155B2 (en) 2012-03-28 2017-08-29 Ixcela, Inc. IPA as a therapeutic agent, as a protective agent, and as a biomarker of disease risk
WO2015116988A2 (en) * 2014-01-31 2015-08-06 Counterpoint Health Solutions, Inc. Covalently bound metabolites as biomarkers
US11041847B1 (en) 2019-01-25 2021-06-22 Ixcela, Inc. Detection and modification of gut microbial population

Also Published As

Publication number Publication date
WO1998010295A1 (en) 1998-03-12
JP3553612B2 (ja) 2004-08-11
CA2264754C (en) 2005-11-22
JP2001502792A (ja) 2001-02-27
ATE217089T1 (de) 2002-05-15
CA2264754A1 (en) 1998-03-12
EP0931265B1 (en) 2002-05-02
DE69712352D1 (de) 2002-06-06
ES2176778T3 (es) 2002-12-01
DE69712352T2 (de) 2002-11-14
US5731208A (en) 1998-03-24
EP0931265A1 (en) 1999-07-28
PT931265E (pt) 2002-09-30
AU4165297A (en) 1998-03-26

Similar Documents

Publication Publication Date Title
PT931264E (pt) Metodo de diagnostico da aterosclerose
DK0931265T3 (da) Diagnistisk metode for aterosklerose
DE69631738D1 (de) Medizinische implantierbare Vorrichtung für elektrochemische Messungen von Bluteigenschaften
NO971348D0 (no) Pröveenhet for oppsamling og undersökelse av kroppsvæske
AU1726797A (en) A method for monitoring the health of a patient by measuring and predicting the glucose level of the patient's blood sample
DE69635174D1 (de) Nichtinvasive Vorrichtung zur Blutuntersuchung
DE69736527D1 (de) Messvorrichtung zur schnellen nichtinvasiven blutdruckbestimmung
DE69623628D1 (de) Virtuelles medizinisches instrument zum medizinischen diagnostiktesten von patienten
DE69531743D1 (de) System und verfahren zur diagnose von krankheiten an lebendem gewebe
AU1364292A (en) Non-invasive device and method for determining concentrations of various components of blood or tissue
ES2147555T3 (es) Ensayo de proteinas de la matriz nuclear en fluidos.
DE69732223D1 (de) Ultraschall-Echographiesystem zur Untersuchung von Arterien
DE69601544D1 (de) Harnsammel und Untersuchungsvorrichtung, und Gebrauchsverfahren
EP0924523A3 (de) Verfahren und Diagnosemittel zum Nachweis von Hämostasestörungen
ATE529743T1 (de) Verfahren und kits zur tumorigenizitätsdiagnose
HU9202178D0 (en) Method for detecting irregularities of bone and other connective tissues in human beings and in animals
AU2634595A (en) A diagnostic method for establishing food intolerance/allergy, and an instrument for use when carrying out the method
ZA98665B (en) Method and apparatus for the measurement of blood coagulation properties with absorbent materials
DE68911574D1 (de) Reagenzsystem zur Bestimmung des Komplexes des menschlichen Plasminogenaktivator-Inhibitors und des menschlichen Gewebeplasminogenaktivators und Testsatz dafür.
WO1992005278A3 (en) Method for the determination of the differential expression of mrna for the amyloid precursor protein (app)
EP0745221A4 (en) PYRIDINOLINE BRIDGES USEFUL FOR INDICATING THE SEVERITY OF PERIODONTIC OR PERIPHERAL CONDITIONS TO AN IMPLANT
IT1276615B1 (it) Metodo per la rivelazione di catecolamine durante il ritmo circadiano, uso di detto metodo per la diagnosi e la terapia di malattie nervose
FR2714812B1 (fr) Procédé de stérilisation d'instruments chirurgicaux et autoclave permettant de la mettre en Óoeuvre.
DE69522935D1 (de) Verfahren zur Erfassung der Geschwindigkeit von Gewebe oder Blut und Ultraschall-Diagnosevorrichtung
WO2001073111A3 (en) Cell-free reconstitution of autophagocytosis